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Figure 4. 293T Extracellular Vesicle Analysis. Here, we are depicting the colocation of the S15-GFP surface 
marker with either LAMP1 and CD63, or LAMP1 and CD81. Dot plots are sectioned into quadrants with 
corresponding percentages. The upper right quadrant quantifies the triple positive puncta, whereas the lower left 
quadrant quantifies the S15-GFP positive puncta alone. Bar graphs represent the summation of each quadrant, 









































































































































Cell Type EV Max Intensity Comparison 
Analysis   
95,101             125,088                204,263             26,136      
  
        113,700                 66,090                  79,338                   110,850 
 
 
Figure	6.	Cell	Type	EV	Max	Intensity	Comparison	
Here,	we	are	comparing	the	fluorophore	signal	intensity	of	all	puncta	from	each	
surface	mask	created.	The	red	numbers	represent	the	total	puncta	number.	
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Figure	7:	Extracellular	Vesicle	Protein	Co-Localization	Analysis.	This	data	shows	the	summation	of	both	
S15-GFP	293T	and	GFP	MSC	vesicle	co-localization	analyses	with	either	CD81,	LAMP1,	CD81	and	LAMP1	
(top),	or	CD63,	LAMP1,	or	CD63	and	LAMP1	(bottom).	Bar	graphs	represent	the	summation	of	each	
protein	co-localization	analysis,	with	corresponding	colors.		
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CHAPTER	FIVE	
CELL	SURFACE	MARKERS	OF	EXTRACELLULAR	VESICLES	CONTAINING	HIV-1	PROTEINS	RELEVANT	
TO	HAND	
Materials	and	Methods	
Cell	Culture.		
HEK	293T	(293T)	cells	were	cultured	at	37	degrees	Celsius	and	5	percent	Carbon	Dioxide	
in	Dulbecco’s	modified	Eagle’s	Medium	(DMEM)	containing	phenol	red	(Invitrogen),	
supplemented	with	the	addition	of	10	percent	fetal	bovine	serum	(FBS)	(Hyclone),	100	IU/ml	
penicillin,	100	ug/ml	streptomycin	and	10	ug/ml	ciprofloxacin	hydrochloride.		
THP-1	cells	were	cultured	at	37	degrees	Celsius	and	5	percent	Carbon	Dioxide	in	Roswell	
Park	Memorial	Institute	medium	(RPMI)	containing	phenol	red	(Invitrogen),	supplemented	with	
the	addition	of	10	percent	fetal	bovine	serum	(FBS)	(Hyclone),	100	IU/ml	penicillin,	100	ug/ml	
streptomycin	and	10	ug/ml	ciprofloxacin	hydrochloride.		
Protein-GFP	Fusion	Constructs.		
Expression	plasmids	encoding	HIV-1	proteins	Nef,	Tat	and	Vpr	were	generated	by	PCR–
based	strategy.	First,	HIV-1	viral	proteins	Tat	and	Nef	were	fused	to	the	N-terminus	of	GFP	in	a	
pEGFP-N1	backbone	(Figure	7B,	7C).	Following	this,	the	Tat-GFP	fused	protein	was	subcloned	
into	the	multiple	cloning	site	of	the	lentiviral	backbone	(pLVX)	by	PCR-based	strategy	(Figure	
7A).			
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Transfection	of	Protein-GFP	Constructs	and	Generation	of	Stable	TAT-GFP	Cell	Line.	
293T	cells	were	transfected	at	approximately	60	percent	confluency	using	
Polyethylenimine	(PEI),	with	either	the	NEF-GFP-N1,	TAT-GFP-N1	or	GFP-VPR	plasmid.	Cell	
supernatant	was	collected	48,	72	and	96	hours	post-transfection	for	extracellular	vesicle	
collection	via	differential	ultracentrifugation.		
Lentivirus	for	transduction	was	produced	by	transfection	of	293T	cells	with	equal	parts	
of	vesicular	stomatitis	virus	glycoprotein	(VSV-G),	packaging	construct	psPax2,	and	Tat-GFP-
pLVX.	Viruses	were	harvested	48	hours	post-transfection,	filtered	through	a	0.45-µm	filter	
(Millipore),	and	used	to	transduce	THP-1	cells.	Cells	were	selected	48	hours	post-transduction	in	
RPMI	containing	5	µg/ml	puromycin	(Sigma-Aldrich).		
Extracellular	Vesicle	Collection.	
Collected	supernatant	was	first	spun	at	4,000g	for	20	minutes,	10,000g	for	30	minutes	
and	100,000g	for	70	minutes.	The	pelleted	vesicles	were	then	re-suspended	in	PBS	and	spun	at	
100,000g	for	70	minutes.	All	differential	centrifugation	was	performed	in	4	degrees	Celsius.	
Concentrated	extracellular	vesicle	pellets	were	re-suspended	in	PBS	and	stored	at	-80	Celsius.		
Immunofluorescent	Staining.	
For	extracellular	vesicle	visualization	experiments,	collected	vesicles	were	spinoculated	
onto	glass	coverslips	at	13	degrees	Celsius	for	2	hours	at	1200g	and	subsequently	fixed	with	a	
solution	consisting	of	0.1	M	PIPES	and	3.7	percent	formaldehyde	(Polysciences)	for	5	minutes.	
Following	fixation,	vesicles	were	incubated	with	the	following	possible	primary	antibodies	at	a	
		
	
31	
concentration	of	1:1000:	mouse	anti-CD9	(BD	Pharmigen),	mouse	anti-CD63	(BD	Pharmigen),	
mouse	anti-CD81	(BD	Pharmigen),	or	mouse	anti-TSG101	(Santa	Cruz	Biotechnology	Inc.)	along	
with	the	rabbit	anti-Lamp1	antibody	(Abcam),	in	a	PBS	block	solution	supplemented	with	10	
percent	normal	donkey	serum	(NDS),	and	0.01	percent	NaN3	for	1	hour.	Following	primary	
antibody	incubation	vesicles	were	incubated	with	their	respective	secondary	antibody	
conjugated	to	a	fluorophore,	either	donkey	anti-mouse	594-conjugated	or	donkey	anti-rabbit	
647-conjugated,	at	a	concentration	of	1:400,	for	20	minutes	in	the	same,	above	described	PBS	
block	solution.		
Wide-Field	Deconvolution	Microscopy	and	Analysis.	
Extracellular	vesicle	images	were	taken	on	a	DeltaVision	wide	field	fluorescent	
microscope	(Applied	Precision,	GE)	outfitted	with	a	digital	camera	(CoolSNAP	HQ;	
Photometrics),	while	using	a	1.4	numerical	aperture,	and	60	X	objective	lens.	The	acquired	
images	were	deconvolved	with	the	SoftWoRx	deconvolution	software	(Applied	Precision)	and	
analyzed	on	Bitplane:	Imaris	software	version	7.6.4.			
Puncta	were	analyzed	for	vesicle-like	characteristics,	such	as	size	and	sphericity,	and	a	
surface	algorithm	was	built	around	the	GFP	signal.	The	maximum	fluorescence	intensity	found	
within	these	puncta	was	then	analyzed	and	cross	analyzed	with	the	other	perspective	channels.	
Finally,	all	acquired	images	were	subjected	to	the	same	algorithm	via	the	Batch	
Coordinator	tool	(Bitplane)	to	each	respective	signal.	All	statistical	analyses	and	graphs	were	
created	using	GraphPad	Prism	version	5.00	or	6.00	(GraphPad	Software,	Inc.).	
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Results	and	Conclusions	
Extracellular	vesicles	may	be	the	result	of	secretion	directly	from	the	plasma	membrane,	
released	following	the	endocytic	pathway,	or	can	be	the	product	of	autophagic	unconventional	
secretion	(19,	20,	56-58).	Nef	extracellular	vesicles	are	less	than	5	percent	LAMP1	positive	
leading	us	to	believe	that	Nef	may	be	secreted	directly	from	the	plasma	membrane,	as	LAMP1	
is	associated	with	autophagic	unconventional	secretion.		These	data	correlate	well	with	the	
structural	model	of	Nef,	as	this	protein	consists	of	an	N-terminal	myristoylation,	causing	Nef	to	
be	a	membrane-associated	protein	(Figure	9C).	Furthermore,	the	previously	described	S15-GFP	
membrane	marker,	consisting	of	a	myristoylated	glycine	residue	and	positive	charges,	reveal	a	
similar	co-localization	analysis	with	LAMP1	at	approximately	5	percent.	Lastly,	the	extracellular	
vesicles	of	Nef	colocalize	more	so	with	the	tetraspanins	CD63	and	CD81,	of	which	are	known	to	
be	located	in	the	plasma	membrane	of	cells,	rather	than	the	late	endosome/MVB	tetraspanin	
CD9.	
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Figure	9.	Representative	Example	of	Triple	Co-Localization.	Panel	A	is	a	portion	of	the	total	image	achieved	of	
which	three	distinct	channels	are	visible.	Panel	B	reveals	a	number	of	surfaces	which	have	been	created	to	
detect	puncta	within	the	parameters	of	the	set	algorithm.	Triple	colocalization	can	be	detected	in	panel	C,	from	
each	individual	fluorescent	channel:	NEF-GFP	(D),	CD9	(E)	and	LAMP1(F).	
 
Figure	8.	Agarose	Gel	Electrophoresis	of	Generated	HIV-1	Protein	Plasmids.	
Panel	A	depicts	the	Tat-GFP-pLVX	clone.	Panel	B	depicts	the	Tat-pEGFP-N1	
clone.	Panel	C	depicts	the	Nef-pEGFP-N1	clone.		
 
A	 B	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 
 
C	
  
 
		
	
34	
Figure	10.	293T	Nef-GFP	Extracellular	Vesicle	Protein	Co-Localization	Analyses	and	Protein	Structure.	(A)	This	
data	shows	the	summation	of	each	Nef-GFP	antibody	stain;	each	protein	co-localization	analysis	has	3	total	
data	replicates.	Error	bars	show	the	standard	error	of	the	mean.	(B)	Bar	graphs	to	represent	the	summation	of	
each	protein	co-localization	analysis.	(C)	Structural	example	of	HIV-1	protein	Nef.	
 
	
	
	
	
	
	
	
	
	
	
	
	
Unlike	Nef	extracellular	vesicles,	Tat	profiles	are	nearing	20	percent	positive	for	LAMP1,	
suggesting	their	release	is	more	associated	with	the	autophagic	unconventional	secretion	
pathway.	Yet,	as	the	data	present	Tat	often	colocalizes	with	CD63	and	CD81	as	well	suggesting	
their	release	directly	from	the	plasma	membrane.	Although	confounding,	these	Tat	single	
vesicle	analyses	may	lead	to	the	conclusion	that	this	particular	HIV-1	protein	is	packaged	and	
released	within	vesicles	from	multiple,	or	more	than	one	pathway.		
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Similar	to	extracellular	vesicles	released	from	Tat-GFP	293T	cells,	Tat-GFP	THP-1	
extracellular	vesicles	are	nearing	20	percent	positive	for	LAMP1,	yet	expression	of	tetraspanins	
CD9,	CD63,	CD81	and	ESCRT	protein	TSG101	have	all	decreased.	Possibly	THP-1	Tat	vesicles	are	
associated	with	the	autophagic	unconventional	secretion	pathway.		
	
	
	
	
	
Figure	11.	293T	Tat-GFP	Extracellular	Vesicle	Protein	Co-Localization.	This	data	shows	the	summation	of	each	
Tat-GFP	antibody	stain;	each	protein	co-localization	analysis	has	3	total	data	replicates.	Error	bars	show	the	
standard	error	of	the	mean.	Bar	graphs	to	represent	the	summation	of	each	protein	co-localization	analysis.		
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Figure	12.	THP-1	Tat-GFP	Extracellular	Vesicle	Protein	Co-Localization.	This	data	shows	the	summation	of	
each	Tat-GFP	antibody	stain;	each	protein	co-localization	analysis	has	3	total	data	replicates.	Error	bars	show	
the	standard	error	of	the	mean.	Bar	graphs	to	represent	the	summation	of	each	protein	co-localization	
analysis.		
 
	
	
	
	
	
	
	
	
	
	
	
	
	
Extracellular	vesicles	released	from	GFP-Vpr	expressing	293T	cells	present	with	a	protein	
co-localization	profile	more	similar	to	293T	Tat-GFP	vesicles,	than	293T	Nef-GFP	vesicles.	As	the	
data	present,	Vpr	vesicles	are	nearing	25	percent	positive	for	LAMP1,	suggesting	their	release	
are	more	associated	with	the	autophagic	unconventional	secretion	pathway.	Of	the	three	HIV-1	
protein	expressing	extracellular	vesicle	populations,	Vpr	vesicles	have	the	lowest	co-localization	
with	the	tetraspanins	CD9,	CD63	and	CD81,	yet	the	highest	expression	of	ESCRT	protein	
TSG101,	suggesting	that	Vpr	vesicles	may	be	derived	from	an	unconventional	secretion	
pathway	as	TSG101	is	a	protein	found	within	late	endosomes/MVB.				
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Figure	13.	293T	GFP-Vpr	Extracellular	Vesicle	Protein	Co-Localization.	This	data	shows	the	summation	of	each	
GFP-Vpr	antibody	stain;	each	protein	co-localization	analysis	has	3	total	data	replicates.	Error	bars	show	the	
standard	error	of	the	mean.	Bar	graphs	to	represent	the	summation	of	each	protein	co-localization	analysis.		
 
	38	
CHAPTER	SIX	
DISCUSSION	
Extracellular	vesicle	analysis	at	the	level	of	individual	vesicles	provides	a	newfound	
appreciation	of	their	heterogeneous	population,	allowing	for	further	analysis	of	possible	
subpopulations.	Prior	to	this	work	the	techniques	most	often	utilized	to	study	extracellular	
vesicles	were	based	on	the	entire	population,	via	western	blot	or	RT-PCR,	constraining	
viewpoints	of	homogeneity.	The	validated	methodology	provided	in	this	study	has	the	potential	
to	be	utilized	in	the	examination	of	various	extracellular	vesicles	released	from	any	set	of	cells,	
under	a	variety	of	treatment	options,	allowing	a	broader	understanding	of	extracellular	vesicles.	
Moreover,	through	the	use	of	various	protein	markers	such	as	tetraspanins	CD9,	CD63	and	
CD81,	as	well	as	ESCRT	protein	TSG101	and	lysosomal	marker	LAMP1,	it	may	be	possible	to	
determine	the	biogenesis	of	extracellular	vesicles	implicated	in	HAND	pathogenesis.	
Immunofluorescent	staining	and	wide-field	deconvolution	microscopy	coupled	with	canonical	
vesicle	markers	allows	for	the	analysis	of	subpopulations	of	extracellular	vesicles	released	into	
the	extracellular	milieu.		
Results	from	this	study	revealed	that	distinct	vesicles	are	released	within	and	among	cell	
types.	The	S15-GFP	membrane-associated	marker	was	the	way	in	which	extracellular	vesicles	
were	visualized	for	further	analysis.	It	was	found	that	S15-GFP	293T	vesicles	were	less	than	5	
percent	LAMP1	positive	and	were	significantly	more	positive	for	tetraspanins	CD63	or	CD81
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suggesting	their	release	to	be	generated	directly	from	the	plasma	membrane	or	the	classic,	
exocytic	pathway	of	extracellular	biogenesis	rather	than	an	unconventional	autophagic	
secretion.	This	data	correlates	well	with	the	membrane-association	of	the	S15-GFP	marker,	yet	
through	our	analyses	it	became	apparent	that	not	all	extracellular	vesicles	were	S15-GFP	
positive	(especially	those	that	were	LAMP1	positive)	leading	us	to	believe	that	it	would	be	
beneficial	to	study	extracellular	vesicle	populations	with	a	more	inclusive	marker.	Possibly	
membrane-intercalating	fluorescent	dyes	would	be	a	more	appropriate	tool	in	the	analysis	of	
entire	extracellular	populations.	
This	methodology	of	single	vesicle	analysis	was	then	applied	to	a	second	cell	type,	MSCs	
as	they	were	readily	available.	GFP	MSC	extracellular	vesicles	had	a	unique	protein	co-
localization	profile,	being	much	more	LAMP1	positive	compared	to	the	S15-GFP	extracellular	
vesicles	released	from	293T	cells.	Interestingly,	MSCs	have	been	shown	to	have	extremely	high	
autophagosome	concentration	even	during	basal	state	which	correlates	with	the	data	
presented	here	(19).	Their	profile	of	tetraspanins	CD63	and	CD81,	are	insignificant	among	the	
vesicle	population,	yet	as	stated	previously	this	may	be	due,	in	part,	to	the	fact	that	the	primary	
antibody	for	these	tetraspanins	were	against	mouse	of	which	MSCs	are	derived.	It	would	be	of	
interest	to	analyze	MSC	extracellular	vesicles	with	the	appropriate	species	type	antibodies	to	
determine	their	true	tetraspanin	profile.		
	The	extracellular	vesicle	analyses	containing	HIV-1	proteins	relevant	to	HAND	display	
the	possibility	of	utilizing	this	technique	of	extracellular	vesicle	analysis	within	vesicle	
populations	implicated	in	pathogenesis.		HIV-1	proteins	Tat,	Nef	and	Vpr	were	of	interest	due	to	
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their	broad	association	in	HAND,	as	well	as	their	incorporation	into	extracellular	vesicle	
populations.	The	majority	of	these	studies	were	carried	out	with	the	utilization	of	293T	cells,	
allowing	for	the	foundation	of	single	vesicle	analysis	with	the	incorporation	of	HIV-1	proteins.	
As	might	be	expected	it	would	be	of	great	interest	to	continue	such	analyses	in	more	relevant	
cell	types,	such	as	THP-1	cells	differentiated	into	macrophages;	these	cells	would	bring	us	one	
step	closer	to	the	CNS	resident	microglia.		
Extracellular	vesicles	derived	from	cells	over-expressing	GFP	fusions	to	each	of	these	
proteins	of	interest,	present	with	unique	protein	co-localization	analyses.	The	population	of	
Nef-GFP	extracellular	vesicles	was	found	to	be	highly	associated	with	tetraspanins	CD63	and	
CD81	and	less	so	with	CD9,	TSG101	and	LAMP1.	These	data	fall	in	line	with	the	structure	of	Nef,	
as	myristoylation	allows	for	plasma	membrane	association,	much	like	the	S15-GFP	membrane	
marker.	It	would	be	of	great	interest	to	determine	if	other,	more	HIV-1	applicable	cell	lines	such	
as	THP-1	cells,	have	similar	extracellular	vesicle	characterizations.	Unfortunately	for	this	study	
time	did	not	permit	those	analyses.	
	In	comparison,	Tat-GFP	vesicles,	both	derived	from	293T	and	THP-1	cells,	are	more	
inclined	to	be	positive	for	all	markers	including	tetraspanins	CD9,	CD63	and	CD81,	TSG101,	and	
LAMP1.	Quite	possibly	Tat	protein	is	released	within	multiple	vesicle	populations,	derived	from	
various	biogenesis	pathways,	as	literature	suggests	states	of	disease	and	alterations	of	cellular	
metabolism	perturb	the	cells	natural	extracellular	vesicle	biogenesis	pathways	(6,	15,	18,	21).	
Tat,	a	protein	known	to	be	often	secreted	from	HIV-1	infected	cells,	may	incorporate	itself	into	
many	extracellular	populations	for	means	of	exiting	the	cell.	
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Lastly,	GFP-Vpr	extracellular	vesicles	present	with	the	highest	expression	of	ESCRT	
protein	TSG101;	this	suggests	that	their	release	may	be	more	connected	to	the	classic,	exocytic	
pathway	of	extracellular	biogenesis	as	TSG101,	an	ESCRT	protein,	is	often	found	within	late	
endosomes/MVB.	With	hopes	of	studying	this	viral	protein	in	a	more	relevant	HIV-1	disease	
model	cell	line,	THP-1	cells	were	generated	to	express	GFP-Vpr	via	transduction.	Unfortunately,	
these	cells	were	unable	to	thrive	as	the	Vpr	protein	is	known	to	cause	G2	cycle	arrest.	A	
doxycycline-inducible	system	was	of	interest,	as	it	would	potentially	allow	for	limited	
expression	of	Vpr,	yet	despite	many	attempts	it	was	regrettably	unsuccessful	during	this	study.	
After	analyzing	obtained	data	it	became	apparent	that	although	various	markers	were	
utilized	with	the	goal	of	characterizing	the	whole	extracellular	vesicle	populations,	a	large	
proportion	of	vesicles	were	negative	for	any	of	the	chosen	markers.	This	limitation	is	possibly	
the	result	of	surface	algorithms	created	to	detect	positive	puncta.	Such	algorithms	created	for	
each	channel	of	interest	have	been	applied	to	thousands	of	extracellular	vesicles	with	
background	levels	derived	from	the	secondary	antibody	only	controls.	Quite	possibly	during	the	
analysis,	the	detection	methods	utilized	were	too	conservative	excluding	positive	puncta.	
Alternatively,	is	would	be	of	interest	to	include	a	broader	range	of	both	integral,	as	well	as	
transmembrane	proteins	for	further	characterization	of	the	extracellular	vesicle	population.	
Perhaps,	the	inclusion	of	heat	shock	proteins	or	membrane	transport	proteins	may	better	
reveal	the	true	characteristics	of	all	extracellular	vesicles	obtained.		
In	future	studies	involving	extracellular	vesicles	containing	HIV-1	proteins,	it	would	be	
revealing	to	expose	neuronal	cell	lines	to	each	extracellular	vesicle	population	individually	(Nef,	
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Tat,	or	Vpr)	to	determine	their	deleterious	effects.	Quite	possibly	one	protein	is	more	
neurotoxic	than	the	next	or	even	one	pathway	of	extracellular	vesicle	biogenesis	produces	
more	neurotoxic	vesicles.	To	begin	to	address	the	latter,	future	studies	may	utilize	various	
pharmacological	treatments	to	inhibit	one	or	more	extracellular	vesicle	biogenesis	pathways.	
For	instance,	Bafilomycin	A1	may	be	utilized	to	inhibit	the	production	of	lysosomes	or	MG132	
to	perturb	the	formation	of	autophagosome,	thus	altering	pathways	of	cellular	degradation	and	
vesicle	biogenesis.				
Additionally,	it	would	be	meaningful	to	determine	how	prevalent	Nef,	Tat	or	Vpr	are	
among	the	entire	vesicle	population	released	from	HIV-1	infected	cells.	Possibly	as	a	result	of	
HIV-1	infection,	the	extracellular	vesicle	populations	are	altered	even	more	so	than	during	the	
single	protein	expression	induced	here.	To	analyze	the	population	of	extracellular	vesicles	
released	following	HIV-1	infection	would	require	a	reliable	method	of	separating	virus	from	
extracellular	vesicles.	Physical	and	chemical	characteristics,	as	well	as	biogenesis	pathways	are	
almost	identical	between	extracellular	vesicles	and	virions	causing	an	analysis	such	as	this	very	
challenging.		
In	this	thesis	of,	THE	NOVEL	CHARACTERIZATION	OF	EXTRACELLULAR	VESICLES	
CONTAINING	PROTEINS	WHICH	HAVE	BEEN	IMPLICATED	IN	THE	PATHOGENESIS	OF	HIV	
ASSOICIATED	NEUROCOGNITIVE	DISORDERS	we	have	shown	that	extracellular	vesicles	
containing	HIV-1	proteins	are	not	of	a	homogeneous	population.	Through	the	utilization	of	
canonical	markers	and	wide-field	deconvolution	microscopy	we	can	analyze	the	larger	
population	at	the	single	vesicle	level	to	determine	their	possible	mode	of	biogenesis.		This	study	
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provides	the	foundation	in	characterizing	and	better	understanding	extracellular	vesicles	which	
may	be	responsible	for	the	pathogenesis	of	a	multitude	of	neuropathological	disorders.
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